IAMI Trial

• Research type

  Research Study

• Full title

  Influenza vaccination After Myocardial Infarction (IAMI trial). A multicenter, prospective, randomized controlled clinical trial based on the Swedish angiography and angioplasty registry (SCAAR) platform

• IRAS ID

  226902

• Contact name

  Keith Oldroyd

• Contact email

  keith.oldroyd@nhs.net

• Sponsor organisation

  Örebro University Hospital

• Eudract number

  2014-001354-42

• Clinicaltrials.gov Identifier

  NCT02831608

• Duration of Study in the UK

  0 years, 6 months, 2 days

• Research summary

  The IAMI study is a multicentre, prospective, randomised registry-based controlled clinical trial to compare the efficacy of influenza vaccination and placebo in reducing future major adverse cardiac and cerebrovascular events in patients who have had a myocardial infarction.

• REC name

  East Midlands - Leicester South Research Ethics Committee

• REC reference

  17/EM/0234

• Date of REC Opinion

  7 Jul 2017

• REC opinion

  Unfavourable Opinion